Edition:
India

St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

77.55USD
9:44pm IST
Change (% chg)

$0.11 (+0.14%)
Prev Close
$77.44
Open
$77.40
Day's High
$77.71
Day's Low
$77.25
Volume
284,336
Avg. Vol
--
52-wk High
--
52-wk Low
--

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement... (more)

Overall

Beta: 1.26
Market Cap(Mil.): $22,014.44
Shares Outstanding(Mil.): 284.28
Dividend: 0.31
Yield (%): 1.60

Financials

BRIEF-St Jude Medical announces European launch of latest in pressurewire guidewire technology

* Announces European launch of latest in PressureWire Guidewire technology to measure pressure differences across narrowed coronary arteries

18 May 2016

U.S. RESEARCH ROUNDUP-Aflac, St. Jude Medical, Gap

May 10 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Your Community Bankshares, Kohls and Nordic American Tanker, on Tuesday. HIGHLIGHTS * Aflac Inc : FBR cuts to market perform rating * Sprouts Farmers market Inc : Goldman Sachs cuts to sell from neutral * Hasbro Inc : Piper Jaffray cuts to neutral from overweight * St. Jude Medical Inc : SunTrust

10 May 2016

BRIEF-st. Jude medical sets quarterly dividend of $0.31per share

* Sets quarterly dividend of $0.31per share Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

04 May 2016

Abbott deal for St. Jude spurs company split talk

NEW YORK When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Miles White is laying groundwork to split the company yet again.

29 Apr 2016

Abbott deal for St. Jude spurs company split talk

NEW YORK, April 28 When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Miles White is laying groundwork to split the company yet again.

29 Apr 2016

Fitch Places St. Jude Medical on Rating Watch Negative

(The following statement was released by the rating agency) CHICAGO, April 28 (Fitch) Fitch Ratings has placed St. Jude Medical, Inc. (STJ, St. Jude) on Rating Watch Negative. The rating action follows Abbott Laboratories' (ABT, Abbott) announcement of its intention to acquire St. Jude. Fitch will resolve the Rating Watch as more details regarding the transactions become available. However, given the currently available information and assuming Abbott acquires both Alere and St. Jude, Fitch

29 Apr 2016

BRIEF-S&P- Abbott Laboratories ratings remain on creditwatch negative on planned acquisition of St. Jude

* Abbott Laboratories ratings remain on creditwatch negative on planned acquisition of St. Jude Medical Source text: (http://bit.ly/21hkyCp) (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)

28 Apr 2016

BRIEF-Abbott to acquire St. Jude medical

* Transaction expected to be accretive to abbott's adjusted earnings per share(1) in first full year after closing and increasing thereafter

28 Apr 2016

Abbott to acquire St. Jude Medical for $25 bln

April 28 Abbott Laboratories said it agreed to buy medical device maker St. Jude Medical Inc for $25 billion.

28 Apr 2016

Heart failure devices pump up St. Jude's profit, revenue

St. Jude Medical Inc reported better-than-expected quarterly results helped by strong heart failure device sales and said it was making progress in getting its pacemaker and defibrillator business back on track.

20 Apr 2016

Earnings vs. Estimates